Antara Capital LP Tg Therapeutics, Inc. Transaction History

Antara Capital LP

  • $17.8 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.74 - $10.66 $503,639 - $1.44 Million
-134,663 Reduced 13.02%
900,000 $3.83 Million
Q1 2022

May 16, 2022
BUY
$7.81 - $20.45 $7.65 Million - $20 Million
979,263 Added 1767.62%
1,034,663 $9.84 Million
Q3 2021

Nov 15, 2021
BUY
$21.78 - $40.45 $1.21 Million - $2.24 Million
55,400 New
55,400 $1.84 Million

Others Institutions Holding TGTX

# of Institutions
336
Shares Held
87.6M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Antara Capital LP Portfolio

Follow Antara Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Antara Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email